Extracellular Matrix and Oxidative Stress Following Traumatic Spinal Cord Injury: Physiological and Pathophysiological Roles and Opportunities for Therapeutic Intervention.

Jonathon Chon Teng Chio, Nayaab Punjani, Nader Hejrati, Mohammad-Masoud Zavvarian, James Hong, Michael G Fehlings

Journal: Antioxidants & redox signaling 2022;37(1-3):184-207

PMID: 34465134

Abstract

Traumatic spinal cord injury (SCI) causes significant disruption to neuronal, glial, vascular, and extracellular elements. The spinal cord extracellular matrix (ECM) comprises structural and communication proteins that are involved in reparative and regenerative processes after SCI. In the healthy spinal cord, the ECM helps maintain spinal cord homeostasis. After SCI, the damaged ECM limits plasticity and contributes to inflammation through the expression of damage-associated molecules such as proteoglycans. Considerable insights have been gained by characterizing the origins of the gliotic and fibrotic scars, which not only reduce the spread of injury but also limit neuroregeneration. These properties likely limit the success of therapies used to treat patients with SCI. The ECM, which is a major contributor to the scars and normal physiological functions of the spinal cord, represents an exciting therapeutic target to enhance recovery post-SCI. Various ECM-based preclinical therapies have been developed. These include disrupting scar components, inhibiting activity of ECM metalloproteinases, and maintaining iron homeostasis. Biomaterials have also been explored. However, the majority of these treatments have not experienced successful clinical translation. This could be due to the ECM and scars' polarizing roles. This review surveys the complexity involved in spinal ECM modifications, discusses new ECM-based combinatorial strategies, and explores the biomaterials evaluated in clinical trials, which hope to introduce new treatments that enhance recovery after SCI. These topics will incorporate oxidative species, which are both beneficial and harmful in reparative and regenerative processes after SCI, and not often assessed in pertinent literature. . 37, 184-207.

Address: Department of Genetics and Development, Krembil Brain Institute, University Health Network, Toronto, Canada.; Institute of Medical Science, University of Toronto, Toronto, Canada.; Department of Genetics and Development, Krembil Brain Institute, University Health Network, Toronto, Canada.; Department of Genetics and Development, Krembil Brain Institute, University Health Network, Toronto, Canada.; Institute of Medical Science, University of Toronto, Toronto, Canada.; Department of Surgery and Spine Program, University of Toronto, Toronto, Canada.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.